Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning
- PMID: 10490239
- DOI: 10.1080/10715769900301611
Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning
Abstract
Parkinson's disease is characterized by dopaminergic cell death in the substantia nigra. The underlying mechanism is, however, unknown. Though there are increasing lines of evidence showing iron accumulation in the Parkinsonian substantia nigra, it still remains obscure whether increased iron is the primary cause of dopaminergic cell death, or just a consequence of the pathological process. It is also unclear how iron gains access to the Parkinsonian SN. To gain more understanding in these areas, the present study investigated the time course of dopaminergic cell death and of changes in the level of iron, ferritin and transferrin. The results showed that iron was increased after the significant nigral dopaminergic cell death induced by 6-hydroxydopamine injection into the rat substantia nigra. On the other hand, the expression of transferrin was decreased. However, there was a temporal increase in the number of ferritin positive microglia. The results indicated that iron increase was not the primary cause of dopaminergic cell death in the Parkinsonian rat. It was most likely the result of an accumulation of iron-laden microglia.
Similar articles
-
Time-course and localization of transferrin receptor expression in the substantia nigra of 6-hydroxydopamine-induced parkinsonian rats.Neuroscience. 1999;91(2):579-85. doi: 10.1016/s0306-4522(98)00669-1. Neuroscience. 1999. PMID: 10366015
-
Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits.Neuroscience. 2005;135(3):829-38. doi: 10.1016/j.neuroscience.2005.06.049. Epub 2005 Sep 13. Neuroscience. 2005. PMID: 16165292
-
6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra.Brain Res. 2000 Mar 6;858(1):163-6. doi: 10.1016/s0006-8993(99)02459-2. Brain Res. 2000. PMID: 10700609
-
Iron, the substantia nigra and related neurological disorders.Biochim Biophys Acta. 2009 Jul;1790(7):606-14. doi: 10.1016/j.bbagen.2008.08.005. Epub 2008 Aug 20. Biochim Biophys Acta. 2009. PMID: 18778755 Review.
-
Biological fluid levels of iron and iron-related proteins in Parkinson's disease: Review and meta-analysis.Eur J Neurol. 2021 Mar;28(3):1041-1055. doi: 10.1111/ene.14607. Epub 2020 Dec 1. Eur J Neurol. 2021. PMID: 33098743
Cited by
-
Brain Iron Metabolism, Redox Balance and Neurological Diseases.Antioxidants (Basel). 2023 Jun 16;12(6):1289. doi: 10.3390/antiox12061289. Antioxidants (Basel). 2023. PMID: 37372019 Free PMC article. Review.
-
Dose- and time-dependent alpha-synuclein aggregation induced by ferric iron in SK-N-SH cells.Neurosci Bull. 2010 Jun;26(3):205-10. doi: 10.1007/s12264-010-1117-7. Neurosci Bull. 2010. PMID: 20502498 Free PMC article.
-
Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease.J Neural Transm (Vienna). 2011 Mar;118(3):361-9. doi: 10.1007/s00702-010-0434-3. Epub 2010 Jun 17. J Neural Transm (Vienna). 2011. PMID: 20556443
-
Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease.Neurotox Res. 2003;5(1-2):35-44. doi: 10.1007/BF03033371. Neurotox Res. 2003. PMID: 12832223 Review.
-
Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.Biomed Res Int. 2014;2014:581256. doi: 10.1155/2014/581256. Epub 2014 Jan 16. Biomed Res Int. 2014. PMID: 24527451 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical